TSE:BUBurcon NutraScience Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Burcon NutraScience Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$1.36 -0.08 (-5.56 %) (As of 05/29/2020 04:00 PM ET) Add Compare Share Today's RangeC$1.36Now: C$1.36▼C$1.4550-Day RangeC$0.84MA: C$1.28▼C$1.6052-Week RangeC$0.48Now: C$1.36▼C$2.15Volume112,900 shsAverage Volume488,891 shsMarket CapitalizationC$130.04 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsInsider TradesHeadlinesSocial Media Burcon NutraScience Corporation, together with its subsidiary, develops plant protein extraction and purification technology of functional and renewable plant proteins in Canada. Its products include CLARISOY, a soy protein for dairy foods, neutral pH beverages, and coffee creamers/whiteners; and Peazazz, a novel pea protein isolate. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. Burcon NutraScience Corporation was founded in 1998 and is headquartered in Vancouver, Canada.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingBurcon NutraScience has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of C$2.13, Burcon NutraScience has a potential upside of 56.3% from its current price of C$1.36.Amount of Analyst CoverageBurcon NutraScience has only been the subject of 1 research reports in the past 90 days. Previous Next 2.6 Community Rank Outperform VotesBurcon NutraScience has received 255 “outperform” votes. (Add your “outperform” vote.)Underperform VotesBurcon NutraScience has received 239 “underperform” votes. (Add your “underperform” vote.)Community SentimentBurcon NutraScience has received 51.62% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Burcon NutraScience and other stocks. Vote “Outperform” if you believe BU will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BU will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldBurcon NutraScience does not currently pay a dividend.Dividend GrowthBurcon NutraScience does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Burcon NutraScience insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Burcon NutraScience are expected to grow in the coming year, from C($0.05) to C$0.00 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Burcon NutraScience is -22.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Burcon NutraScience is -22.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBurcon NutraScience has a P/B Ratio of 8.89. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.35 out of 5 stars Industry, Sector and Symbol Stock Exchange TSE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolTSE:BU Previous Symbol CUSIPN/A CIKN/A Webwww.burcon.ca Phone+1-604-7330896Debt Debt-to-Equity Ratio48.59 Current Ratio10.75 Quick Ratio10.39Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$39,466.00 Price / Sales3,295.00 Cash FlowC$0.07 per share Price / Cash Flow18.55 Book ValueC$0.15 per share Price / Book8.89Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares95,618,000Market CapC$130.04 million Next Earnings Date7/7/2020 (Estimated) OptionableNot Optionable TSX:BU Rates by TradingView Receive BU News and Ratings via Email Sign-up to receive the latest news and ratings for BU and its competitors with MarketBeat's FREE daily newsletter. Burcon NutraScience (TSE:BU) Frequently Asked Questions How has Burcon NutraScience's stock been impacted by COVID-19 (Coronavirus)? Burcon NutraScience's stock was trading at C$0.99 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BU stock has increased by 37.4% and is now trading at C$1.36. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Burcon NutraScience? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Burcon NutraScience in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Burcon NutraScience. When is Burcon NutraScience's next earnings date? Burcon NutraScience is scheduled to release its next quarterly earnings announcement on Tuesday, July 7th 2020. View our earnings forecast for Burcon NutraScience. What price target have analysts set for BU? 2 brokers have issued 1-year price targets for Burcon NutraScience's stock. Their forecasts range from C$1.75 to C$2.50. On average, they anticipate Burcon NutraScience's share price to reach C$2.13 in the next twelve months. This suggests a possible upside of 56.3% from the stock's current price. View analysts' price targets for Burcon NutraScience. Has Burcon NutraScience been receiving favorable news coverage? News headlines about BU stock have been trending very negative on Sunday, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Burcon NutraScience earned a coverage optimism score of -3.4 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news aboutBurcon NutraScience. Who are some of Burcon NutraScience's key competitors? Some companies that are related to Burcon NutraScience include Cel-Sci (CVM), SIGA Technologies (SIGA), Paradigm Biopharmaceuticals (PAR), Biotest (BIO), Neptune Wellness Solutions (NEPT), Silence Therapeutics (SLN), TELIX Pharmaceutical (TLX), Starpharma (SPL), Medicenna Therapeutics (MDNA), ProMetic Life Sciences (PLI), IMV (IMV), Emblem (EMC), Pfenex (PFNX), Exicure (XCUR) and Fennec Pharmaceuticals (FRX). View all competitors. What other stocks do shareholders of Burcon NutraScience own? Based on aggregate information from My MarketBeat watchlists, some companies that other Burcon NutraScience investors own include Aytu Bioscience (AYTU), Aurora Cannabis (ACB), BlackBerry (BB), Burcon Nutrascience (BUROF), Crescent Point Energy (CPG), First Cobalt (FCC), Alamos Gold (AGI), Applied Materials (AMAT), Algonquin Power & Utilities (AQN) and Kirkland Lake Gold (KL). Who are Burcon NutraScience's key executives? Burcon NutraScience's management team includes the following people: Mr. Johann Franz Tergesen, Pres, CEO & COO (Age 56)Ms. Jade Cheng MBA, CPA, CA, CFO & TreasurerMs. Kam T. Law, Sr. VP of Legal & Corp. Sec. (Age 50)Mr. Randy Willardsen MSc, Sr. VP of ProcessDr. Martin Hans Schweizer, VP of Technical Devel. What is Burcon NutraScience's stock symbol? Burcon NutraScience trades on the Toronto Stock Exchange (TSX) under the ticker symbol "BU." How do I buy shares of Burcon NutraScience? Shares of BU and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is Burcon NutraScience's stock price today? One share of BU stock can currently be purchased for approximately C$1.36. How big of a company is Burcon NutraScience? Burcon NutraScience has a market capitalization of C$130.04 million and generates C$39,466.00 in revenue each year. What is Burcon NutraScience's official website? The official website for Burcon NutraScience is www.burcon.ca. How can I contact Burcon NutraScience? Burcon NutraScience's mailing address is 1946 Broadway W, VANCOUVER, BC V6J 1Z2, Canada. The company can be reached via phone at +1-604-7330896. This page was last updated on 5/31/2020 by MarketBeat.com Staff
